HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

ALPK1 Expression Is Associated with Lymph Node Metastasis and Tumor Growth in Oral Squamous Cell Carcinoma Patients.

Abstract
Oral squamous cell carcinoma (OSCC) is the most common malignant cancer, with high mortality rates in advanced stages. Recent studies have shown that the expression of ALPK1 mRNA and its inhibitory differentiation function are associated with cancer progression. However, the expression and clinicopathologic features of ALPK1 in OSCC remain unexplored. Herein, the authors investigated the expression patterns of ALPK1 in 39 matched OSCC patients and examined the relationship between ALPK1 protein expression and clinicopathologic factors using immunohistochemical scores. Using Western blot analysis, ALPK1 expression was found to be significantly higher in tumor tissues than that in nontumor tissues. Through an immunoreactive scoring system, a significantly higher number of advanced-stage tumor size T4 and lymph node metastasis N2 exhibited higher ALPK1 expression levels than that exhibited by T1/T2/T3 tumors and N0/N1. In addition, ALPK1 protein expression was aberrant in malignant oral cancer cell lines compared with that in pre-malignant oral epithelial cells, whereas minimal expression was observed in normal oral epithelial cells. Knockdown of ALPK1 resulted in a significant reduction in cell growth, migration, and invasion capacity in vitro. Consequently, expression of N-cadherin and vimentin decreased in ALPK1-deficient cells. Thus, these results suggest that ALPK1 serves as a potential biomarker and target for OSCC development in late stages.
AuthorsPo-Ku Chen, Chun-Hung Hua, Hui-Ting Hsu, Tzer-Min Kuo, Chia-Min Chung, Chi-Pin Lee, Ming-Hsui Tsai, Kun-Tu Yeh, Ying-Chin Ko
JournalThe American journal of pathology (Am J Pathol) Vol. 189 Issue 1 Pg. 190-199 (01 2019) ISSN: 1525-2191 [Electronic] United States
PMID30315765 (Publication Type: Clinical Trial, Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2018 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.
Chemical References
  • Antigens, CD
  • Biomarkers, Tumor
  • CDH2 protein, human
  • Cadherins
  • Neoplasm Proteins
  • VIM protein, human
  • Vimentin
  • Protein Kinases
  • ALPK1 protein, human
Topics
  • Adult
  • Antigens, CD (genetics, immunology, metabolism)
  • Biomarkers, Tumor (biosynthesis, genetics, immunology)
  • Cadherins (genetics, immunology, metabolism)
  • Carcinoma, Squamous Cell (enzymology, genetics, immunology, pathology)
  • Cell Line, Tumor
  • Female
  • Gene Expression Regulation, Enzymologic
  • Gene Expression Regulation, Neoplastic
  • Gene Knockdown Techniques
  • Humans
  • Keratinocytes (immunology, metabolism, pathology)
  • Lymphatic Metastasis (genetics, immunology, pathology)
  • Male
  • Middle Aged
  • Neoplasm Proteins (biosynthesis, genetics, immunology)
  • Neoplasm Staging
  • Protein Kinases (biosynthesis, genetics, immunology)
  • Tongue Neoplasms (enzymology, genetics, immunology, pathology)
  • Vimentin (genetics, immunology, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: